Coadministration of tacrolimus with anti-acid drugs

Transplantation

Volumn 76, Issue 4, 2003, Pages 665-666

  Chisholm, Marie A ^a,b   Mulloy, Laura L ^b   Jagadeesan, Muralidharan ^b   DiPiro, Joseph T ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM MAGNESIUM HYDROXIDE; ANTACID AGENT; BICARBONATE; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; MAGNESIUM OXIDE; OMEPRAZOLE; PROTON PUMP INHIBITOR; TACROLIMUS; TUMS;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG DEGRADATION; DRUG METABOLISM; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; STOMACH PH;

ADULT; ANTACIDS; DRUG INTERACTIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; TACROLIMUS;

EID: 0041835987     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000072339.10649.9C     Document Type: Article

References (4)

1. Venkataramanan R, Swaminathan A, Prasad T, et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 1995; 29: 404.
2. Steeves M, Abdallah Y, Venkataramanan R, et al. In-vitro interaction of a novel immunosuppressant, FK 506, and antacids. J Pharm Pharmacol 1991; 43: 574.
3. Chisholm MA. Issues of adherence to immunosuppressant therapy after solid-organ transplantation. Drugs 2002; 62: 567.
4. Holum MB, Wisemandle W, Bekersky I. Effects of magnesia and alumina liquid antacid (Maalox) on the absorption of tacrolimus (Prograf) in healthy volunteers. Deerfield IL, Fujisawa Healthcare 2002.